Clinical Trial

Tdap Vaccination During Pregnancy or Postpartum and Lactation-Related Outcomes

Completed
View on ClinicalTrials.gov →
Summary
A retrospective cohort study based on the secondary use of pre-existing data. The study assesses the association between antenatal and postpartum maternal Tdap vaccination and select infant and lactation-related outcomes.
Trial Details
NCT Number NCT07735767
Lead Sponsor HealthPartners Institute
Collaborators: Sanofi, Kaiser Permanente
Conditions Pertussis Vaccines
Enrollment 36,245 participants
Start Date 2014-01
Primary Completion 2022-12 (estimated)
Study Completion 2022-12 (estimated)
Updated on ClinicalTrials.gov 2026-07-30